Ketabat, F.; Pundir, M.; Mohabatpour, F.; Lobanova, L.; Koutsopoulos, S.; Hadjiiski, L.; Chen, X.; Papagerakis, P.; Papagerakis, S.
Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives. Pharmaceutics 2019, 11, 302.
https://doi.org/10.3390/pharmaceutics11070302
AMA Style
Ketabat F, Pundir M, Mohabatpour F, Lobanova L, Koutsopoulos S, Hadjiiski L, Chen X, Papagerakis P, Papagerakis S.
Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives. Pharmaceutics. 2019; 11(7):302.
https://doi.org/10.3390/pharmaceutics11070302
Chicago/Turabian Style
Ketabat, Farinaz, Meenakshi Pundir, Fatemeh Mohabatpour, Liubov Lobanova, Sotirios Koutsopoulos, Lubomir Hadjiiski, Xiongbiao Chen, Petros Papagerakis, and Silvana Papagerakis.
2019. "Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives" Pharmaceutics 11, no. 7: 302.
https://doi.org/10.3390/pharmaceutics11070302
APA Style
Ketabat, F., Pundir, M., Mohabatpour, F., Lobanova, L., Koutsopoulos, S., Hadjiiski, L., Chen, X., Papagerakis, P., & Papagerakis, S.
(2019). Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives. Pharmaceutics, 11(7), 302.
https://doi.org/10.3390/pharmaceutics11070302